Hugo F. Azurmendi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hugo F. Azurmendi has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Darón I. Freedberg
Laboratory of Bacterial Polysaccharides, Division of Bacterial, Parasitic, and Allergenic Products, Center for Biologics Evaluation and Research, US FDA , Silver Spring, MD, 20993
3 shared publications - Arturo Casadevall
Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University
2 shared publications - Audra A. Hargett
Laboratory of Bacterial Polysaccharides, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993
2 shared publications - Stefan Oscarson
Centre for Synthesis and Chemical Biology, University College Dublin, Belfield, Dublin, Ireland
2 shared publications Conor J. Crawford
W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205
1 shared publication- Conor J. Crawford
Max Planck Institute for Colloids and Interfaces
1 shared publication
Latest Publications
- Open Access
- 8 February 2024
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 121 (7)
The structure of a Cryptococcus neoformans polysaccharide motif recognized by protective antibodies: A combined NMR and MD study
Cryptococcus neoformans is a fungal pathogen responsible for cryptococcosis and cryptococcal meningitis. The C. neoformans ’ capsular polysaccharide and its shed exopolysaccharide function both as key virulence factors and to protect the fungal cell from phagocytosis. Currently, a glycoconjugate of these polysaccharides is being explored as a vaccine to protect against C. neoformans infection. In this study, NOE and J -coupling values from NMR experiments were consistent with a converged structure of the synthetic decasaccharide, GXM10-Ac 3 , calculated from MD simulations. GXM10-Ac 3 was designed as an extension of glucuronoxylomannan (GXM) polysaccharide motif (M2) which is common in the clinically predominant serotype A strains and is recognized by protective forms of GXM-specific monoclonal antibodies. The M2 motif is a hexasaccharide with a three-residue α-mannan backbone, modified by β-(1→2)-xyloses (Xyl) on the first two mannoses (Man) and a β-(1→2)-glucuronic acid (GlcA) on the third Man. Combined NMR and MD analyses reveal that GXM10-Ac 3 adopts an extended structure, with Xyl/GlcA branches alternating sides along the α-mannan backbone. O -acetyl esters also alternate sides and are grouped in pairs. MD analysis of a twelve M2-repeating unit polymer supports the notion that the GXM10-Ac 3 structure is uniformly represented throughout the polysaccharide. This derived GXM model displays high flexibility while maintaining a structural identity, yielding insights to further explore intermolecular interactions between polysaccharides, interactions with anti-GXM mAbs, and the cryptococcal polysaccharide architecture.
- 8 February 2024
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 121 (7)
Open AccessThe structure of a Cryptococcus neoformans polysaccharide motif recognized by protective antibodies: A combined NMR and MD study
Cryptococcus neoformans is a fungal pathogen responsible for cryptococcosis and cryptococcal meningitis. The C. neoformans ’ capsular polysaccharide and its shed exopolysaccharide function both as key virulence factors and to protect the fungal cell from phagocytosis. Currently, a glycoconjugate of these polysaccharides is being explored as a vaccine to protect against C. neoformans infection. In this study, NOE and J -coupling values from NMR experiments were consistent with a converged structure of the synthetic decasaccharide, GXM10-Ac 3 , calculated from MD simulations. GXM10-Ac 3 was designed as an extension of glucuronoxylomannan (GXM) polysaccharide motif (M2) which is common in the clinically predominant serotype A strains and is recognized by protective forms of GXM-specific monoclonal antibodies. The M2 motif is a hexasaccharide with a three-residue α-mannan backbone, modified by β-(1→2)-xyloses (Xyl) on the first two mannoses (Man) and a β-(1→2)-glucuronic acid (GlcA) on the third Man. Combined NMR and MD analyses reveal that GXM10-Ac 3 adopts an extended structure, with Xyl/GlcA branches alternating sides along the α-mannan backbone. O -acetyl esters also alternate sides and are grouped in pairs. MD analysis of a twelve M2-repeating unit polymer supports the notion that the GXM10-Ac 3 structure is uniformly represented throughout the polysaccharide. This derived GXM model displays high flexibility while maintaining a structural identity, yielding insights to further explore intermolecular interactions between polysaccharides, interactions with anti-GXM mAbs, and the cryptococcal polysaccharide architecture.
- Open Access
The structure of a C. neoformans polysaccharide motif recognized by protective antibodies: A combined NMR and MD study
Cryptococcus neoformans is a fungal pathogen responsible for cryptococcosis and cryptococcal meningitis. The C. neoformans capsular polysaccharide and shed exopolysaccharide functions both as a key virulence factor and to protect the fungal cell from phagocytosis. Currently, a glycoconjugate of these polysaccharides is being explored as a vaccine to protect against C. neoformans infection. In this combined NMR and MD study, experimentally determined NOEs and J -couplings support a structure of the synthetic decasaccharide, GXM10-Ac 3 , obtained by MD. GXM10-Ac 3 was designed as an extension of glucuronoxylomannan (GXM) polysaccharide motif (M2) which is common in the clinically predominant serotype A strains and is recognized by protective forms of GXM-specific monoclonal antibodies. The M2 motif is characterized by a 6-residue α-mannan backbone repeating unit, consisting of a triad of α-(1→3)-mannoses, modified by β-(1→2)-xyloses on the first two mannoses and a β-(1→2)-glucuronic acid on the third mannose. The combined NMR and MD analyses reveal that GXM10-Ac 3 adopts an extended structure, with xylose/glucuronic acid branches alternating sides along the α-mannan backbone. O -acetyl esters also alternate sides and are grouped in pairs. MD analysis of a twelve M2-repeating unit polymer supports the notion that the GXM10-Ac 3 structure is uniformly represented throughout the polysaccharide. This experimentally consistent GXM model displays high flexibility while maintaining a structural identity, yielding new insights to further explore intermolecular interactions between polysaccharides, interactions with anti-GXM mAbs, and the cryptococcal polysaccharide architecture. Significance Statement: This study utilized a combined NMR and MD approach to elucidate the structure of a Cryptococcus neoformans GXM synthetic decasaccharide (GXM10-Ac 3 ), recognized by protective anti-GXM mAbs. The data revealed an extended structure in which the xylose/glucuronic acid branches and pairs of 6- O -acetyl esters predominantly alternate sides along the α-mannan backbone. MD analysis of a GXM polysaccharide predicts that the decasaccharide structure is uniformly represented in the polysaccharide. Additionally, the GXM exhibits high flexibility while maintaining structural identity. These findings lay the foundation for future studies aimed at understanding anti-GXM antibody-polysaccharide interactions.
Open AccessThe structure of a C. neoformans polysaccharide motif recognized by protective antibodies: A combined NMR and MD study
Cryptococcus neoformans is a fungal pathogen responsible for cryptococcosis and cryptococcal meningitis. The C. neoformans capsular polysaccharide and shed exopolysaccharide functions both as a key virulence factor and to protect the fungal cell from phagocytosis. Currently, a glycoconjugate of these polysaccharides is being explored as a vaccine to protect against C. neoformans infection. In this combined NMR and MD study, experimentally determined NOEs and J -couplings support a structure of the synthetic decasaccharide, GXM10-Ac 3 , obtained by MD. GXM10-Ac 3 was designed as an extension of glucuronoxylomannan (GXM) polysaccharide motif (M2) which is common in the clinically predominant serotype A strains and is recognized by protective forms of GXM-specific monoclonal antibodies. The M2 motif is characterized by a 6-residue α-mannan backbone repeating unit, consisting of a triad of α-(1→3)-mannoses, modified by β-(1→2)-xyloses on the first two mannoses and a β-(1→2)-glucuronic acid on the third mannose. The combined NMR and MD analyses reveal that GXM10-Ac 3 adopts an extended structure, with xylose/glucuronic acid branches alternating sides along the α-mannan backbone. O -acetyl esters also alternate sides and are grouped in pairs. MD analysis of a twelve M2-repeating unit polymer supports the notion that the GXM10-Ac 3 structure is uniformly represented throughout the polysaccharide. This experimentally consistent GXM model displays high flexibility while maintaining a structural identity, yielding new insights to further explore intermolecular interactions between polysaccharides, interactions with anti-GXM mAbs, and the cryptococcal polysaccharide architecture. Significance Statement: This study utilized a combined NMR and MD approach to elucidate the structure of a Cryptococcus neoformans GXM synthetic decasaccharide (GXM10-Ac 3 ), recognized by protective anti-GXM mAbs. The data revealed an extended structure in which the xylose/glucuronic acid branches and pairs of 6- O -acetyl esters predominantly alternate sides along the α-mannan backbone. MD analysis of a GXM polysaccharide predicts that the decasaccharide structure is uniformly represented in the polysaccharide. Additionally, the GXM exhibits high flexibility while maintaining structural identity. These findings lay the foundation for future studies aimed at understanding anti-GXM antibody-polysaccharide interactions.
- 23 April 2017
- Published by Royal Society of Chemistry (RSC)
- p. 1-19
Intramolecular Hydrogen Bonding in Glycans in Aqueous Solution
Hydrogen bonding is a vital feature of biomolecular structure. Hydrogen bonds help proteins, DNA and RNA fold, giving rise to their shape and are thus an important factor in molecular recognition. Hydrogen bonds have been identified in aqueous solutions in proteins and nucleic acids, however, they have not been detected in aqueous solutions of glycans. In this chapter, we discuss the detection of hydrogen bonds in aqueous solution by NMR spectroscopy. These include NH-, OH- and CH-based hydrogen bonds. We describe methods for their detection and the types of hydrogen bonds that have been identified in glycans thus far. We also show how hydrogen bonds in glycans help form helices and other structures, which may affect the shape of these glycans and thus contribute to their flexibility and function.
- 23 April 2017
- Published by Royal Society of Chemistry (RSC)
- p. 1-19
Intramolecular Hydrogen Bonding in Glycans in Aqueous Solution
Hydrogen bonding is a vital feature of biomolecular structure. Hydrogen bonds help proteins, DNA and RNA fold, giving rise to their shape and are thus an important factor in molecular recognition. Hydrogen bonds have been identified in aqueous solutions in proteins and nucleic acids, however, they have not been detected in aqueous solutions of glycans. In this chapter, we discuss the detection of hydrogen bonds in aqueous solution by NMR spectroscopy. These include NH-, OH- and CH-based hydrogen bonds. We describe methods for their detection and the types of hydrogen bonds that have been identified in glycans thus far. We also show how hydrogen bonds in glycans help form helices and other structures, which may affect the shape of these glycans and thus contribute to their flexibility and function.